Cargando…

Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors

Background and Aim. p53 activity plays a role in muscle homeostasis and skeletal muscle differentiation; all pathways that lead to sarcopenia are related to p53 activities. We investigate the allelic frequency of the TP53 codon 72 in exon 4 polymorphism in the Italian female population and the assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Renzo, Laura, Gratteri, Santo, Sarlo, Francesca, Cabibbo, Andrea, Colica, Carmen, De Lorenzo, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211310/
https://www.ncbi.nlm.nih.gov/pubmed/25371596
http://dx.doi.org/10.1155/2014/743634
_version_ 1782341550322221056
author Di Renzo, Laura
Gratteri, Santo
Sarlo, Francesca
Cabibbo, Andrea
Colica, Carmen
De Lorenzo, Antonino
author_facet Di Renzo, Laura
Gratteri, Santo
Sarlo, Francesca
Cabibbo, Andrea
Colica, Carmen
De Lorenzo, Antonino
author_sort Di Renzo, Laura
collection PubMed
description Background and Aim. p53 activity plays a role in muscle homeostasis and skeletal muscle differentiation; all pathways that lead to sarcopenia are related to p53 activities. We investigate the allelic frequency of the TP53 codon 72 in exon 4 polymorphism in the Italian female population and the association with appendicular skeletal muscle mass index in normal weight (NW), normal weight obese (NWO), and preobese-obese (Preob-Ob) subjects. Methods. We evaluated anthropometry, body composition, and p53 polymorphism in 140 women distinguished in NW, NWO, and Preob-Ob. Results. *Arg/*Arg genotype increases sarcopenia risk up to 20% (*Arg/*Arg genotype OR = 1.20; 95% CI = 0.48–2.9; *proallele carriers OR = 0.83; 95% CI = 0.83–2.06). The risk of being sarcopenic for *Arg/*Arg genotype in NWO and Preob-Ob is 31% higher than NW carriers of *proallele (RR = 0,31, 95% CI = 0,15–0,66, P = 0,0079). We developed a model able to predict sarcopenia risk based on age, body fat, and p53 polymorphism. Conclusion. Our study evidences that genotyping TP53 polymorphism could be a useful new genetic approach, in association with body composition evaluations, to assess sarcopenia risk.
format Online
Article
Text
id pubmed-4211310
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42113102014-11-04 Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors Di Renzo, Laura Gratteri, Santo Sarlo, Francesca Cabibbo, Andrea Colica, Carmen De Lorenzo, Antonino Dis Markers Research Article Background and Aim. p53 activity plays a role in muscle homeostasis and skeletal muscle differentiation; all pathways that lead to sarcopenia are related to p53 activities. We investigate the allelic frequency of the TP53 codon 72 in exon 4 polymorphism in the Italian female population and the association with appendicular skeletal muscle mass index in normal weight (NW), normal weight obese (NWO), and preobese-obese (Preob-Ob) subjects. Methods. We evaluated anthropometry, body composition, and p53 polymorphism in 140 women distinguished in NW, NWO, and Preob-Ob. Results. *Arg/*Arg genotype increases sarcopenia risk up to 20% (*Arg/*Arg genotype OR = 1.20; 95% CI = 0.48–2.9; *proallele carriers OR = 0.83; 95% CI = 0.83–2.06). The risk of being sarcopenic for *Arg/*Arg genotype in NWO and Preob-Ob is 31% higher than NW carriers of *proallele (RR = 0,31, 95% CI = 0,15–0,66, P = 0,0079). We developed a model able to predict sarcopenia risk based on age, body fat, and p53 polymorphism. Conclusion. Our study evidences that genotyping TP53 polymorphism could be a useful new genetic approach, in association with body composition evaluations, to assess sarcopenia risk. Hindawi Publishing Corporation 2014 2014-10-13 /pmc/articles/PMC4211310/ /pubmed/25371596 http://dx.doi.org/10.1155/2014/743634 Text en Copyright © 2014 Laura Di Renzo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Di Renzo, Laura
Gratteri, Santo
Sarlo, Francesca
Cabibbo, Andrea
Colica, Carmen
De Lorenzo, Antonino
Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors
title Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors
title_full Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors
title_fullStr Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors
title_full_unstemmed Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors
title_short Individually Tailored Screening of Susceptibility to Sarcopenia Using p53 Codon 72 Polymorphism, Phenotypes, and Conventional Risk Factors
title_sort individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211310/
https://www.ncbi.nlm.nih.gov/pubmed/25371596
http://dx.doi.org/10.1155/2014/743634
work_keys_str_mv AT direnzolaura individuallytailoredscreeningofsusceptibilitytosarcopeniausingp53codon72polymorphismphenotypesandconventionalriskfactors
AT gratterisanto individuallytailoredscreeningofsusceptibilitytosarcopeniausingp53codon72polymorphismphenotypesandconventionalriskfactors
AT sarlofrancesca individuallytailoredscreeningofsusceptibilitytosarcopeniausingp53codon72polymorphismphenotypesandconventionalriskfactors
AT cabibboandrea individuallytailoredscreeningofsusceptibilitytosarcopeniausingp53codon72polymorphismphenotypesandconventionalriskfactors
AT colicacarmen individuallytailoredscreeningofsusceptibilitytosarcopeniausingp53codon72polymorphismphenotypesandconventionalriskfactors
AT delorenzoantonino individuallytailoredscreeningofsusceptibilitytosarcopeniausingp53codon72polymorphismphenotypesandconventionalriskfactors